Report
Michael B. Schäfer

Symrise : Preliminary H2 EBITDA 7% below cons, despite slightly better sales on 11.5% organic sales growth in Q4, €126m impairment, promises 'attractive dividend'

>Preliminary FY 2022 sales incl. 11.4% organic growth (cons 10.7%), implies 11.5% organic growth in Q4 (cons 10.1%) - Symrise reported preliminary sales of € 4,619m in FY 2022, slightly above the consensus expectations of € 4,583m without providing additional segment details. Implied preliminary sales of € 1,125m in Q4 2022 are up 19.4% y-to-y including 11.5% organic sales growth. This is above the consensus of 10.1% for organic sales growth, deteriorating sequentiall...
Underlying
Symrise AG

Symrise AG develops, produces, and sells fragrances and flavors as well as active ingredients for the cosmetics industry. Co. operates in two main business segments: The Scent & Care segment, which develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances; and The Flavor & Nutrition segment, which develops, produces and sells flavors that are used by customers in the production of food products (savory and sweet food products as well as dairy products) and beverages.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Michael B. Schäfer

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch